VEDI ANCHE...
ACE Anticorpi
Empty Table Header | Nome del prodotto | CATALOG # | Isotipo | Epitopo | Applicazione | Species | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|---|
ACE Anticorpo (2E2) | sc-23908 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 37 | ||
ACE Anticorpo (5C5) | sc-23909 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P) | m, r, h | 3 | ||
ACE Anticorpo (H-9) | sc-376132 | mouse IgA | 1279-1306 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
ACE Anticorpo (3H533) | sc-69991 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P) | m, r, h | new | ||
ACE Anticorpo (B-6) | sc-374198 | mouse IgG2b κ | 1279-1306 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
ACE Anticorpo (E-9) | sc-271860 | mouse IgG1 κ | 1-170 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
ACE Anticorpo (2Q2296) | sc-69994 | mouse IgG1 | N/A | WB, IF, IHC(P) | m, r, h, bovine, feline and canine | new | ||
ACE Anticorpo (2Q2297) | sc-69993 | mouse IgG1 | N/A | WB, IF, IHC(P) | m, r, h, bovine, feline and canine | new | ||
ACE Anticorpo (3H536) | sc-69992 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P) | m, r, h | new | ||
ACE2 Anticorpo (E-11) | sc-390851 | mouse IgG1 κ | 631-805 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 99 | ||
ACE2 Anticorpo (AC18Z) | sc-73668 | mouse IgG2a | 18-740 (h) | WB, IP, IF, IHC(P) | h | 17 |
ACE CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|
ACE Plasmide KO CRISPR/Cas9 (h) | sc-400759 | h | Gene Knockout | GFP | 0 | ||
ACE Plasmide KO CRISPR/Cas9 (h2) | sc-400759-KO-2 | h | Gene Knockout | GFP | 0 | ||
ACE Plasmide HDR (h2) | sc-400759-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
ACE Plasmide Double Nickase (h) | sc-400759-NIC | h | Gene Knockout | Puromycin | 0 | ||
ACE Plasmide Double Nickase (h2) | sc-400759-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ACE Plasmide KO CRISPR/Cas9 (m) | sc-418942 | m | Gene Knockout | GFP | 0 | ||
ACE Plasmide HDR (m) | sc-418942-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ACE Plasmide Double Nickase (m) | sc-418942-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACE Plasmide Double Nickase (m2) | sc-418942-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ACE2 Plasmide KO CRISPR/Cas9 (h2) | sc-401131-KO-2 | h | Gene Knockout | GFP | 1 | ||
ACE2 Plasmide HDR (h2) | sc-401131-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
ACE2 Plasmide Double Nickase (h) | sc-401131-NIC | h | Gene Knockout | Puromycin | 1 | ||
ACE2 Plasmide Double Nickase (h2) | sc-401131-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
ACE2 Plasmide KO CRISPR/Cas9 (m) | sc-427594 | m | Gene Knockout | GFP | 0 | ||
ACE2 Plasmide HDR (m) | sc-427594-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ACE2 Plasmide Double Nickase (m) | sc-427594-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACE2 Plasmide Double Nickase (m2) | sc-427594-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ACE CRISPR Activation Products
Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|
ACE Plasmide di attivazione CRISPR (h) | sc-400759-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Plasmide di attivazione CRISPR (h2) | sc-400759-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Particelle di Attivazione Lentivirale (h) | sc-400759-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Particelle di Attivazione Lentivirale (h2) | sc-400759-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Plasmide di attivazione CRISPR (m) | sc-418942-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Plasmide di attivazione CRISPR (m2) | sc-418942-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Particelle di Attivazione Lentivirale (m) | sc-418942-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE Particelle di Attivazione Lentivirale (m2) | sc-418942-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE2 Plasmide di attivazione CRISPR (h) | sc-401131-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACE2 Plasmide di attivazione CRISPR (h2) | sc-401131-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACE2 Particelle di Attivazione Lentivirale (h) | sc-401131-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACE2 Particelle di Attivazione Lentivirale (h2) | sc-401131-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
ACE2 Plasmide di attivazione CRISPR (m) | sc-427594-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE2 Plasmide di attivazione CRISPR (m2) | sc-427594-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE2 Particelle di Attivazione Lentivirale (m) | sc-427594-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACE2 Particelle di Attivazione Lentivirale (m2) | sc-427594-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
ACE siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|
ACE siRNA (h2) | sc-270350 | h | Gene Silencing | N/A | 3 | ||
ACE Plasmide shRNA (h2) | sc-270350-SH | h | Gene Silencing | Puromycin | 3 | ||
ACE shRNA (h2) Particelle lentivirali | sc-270350-V | h | Gene Silencing | Puromycin | 3 | ||
ACE siRNA (m) | sc-29627 | m | Gene Silencing | N/A | 0 | ||
ACE Plasmide shRNA (m) | sc-29627-SH | m | Gene Silencing | Puromycin | 0 | ||
ACE shRNA (m) Particelle lentivirali | sc-29627-V | m | Gene Silencing | Puromycin | 0 | ||
ACE2 siRNA (h) | sc-41400 | h | Gene Silencing | N/A | 6 | ||
ACE2 Plasmide shRNA (h) | sc-41400-SH | h | Gene Silencing | Puromycin | 6 | ||
ACE2 shRNA (h) Particelle lentivirali | sc-41400-V | h | Gene Silencing | Puromycin | 6 | ||
ACE2 siRNA (m) | sc-41401 | m | Gene Silencing | N/A | 3 | ||
ACE2 Plasmide shRNA (m) | sc-41401-SH | m | Gene Silencing | Puromycin | 3 | ||
ACE2 shRNA (m) Particelle lentivirali | sc-41401-V | m | Gene Silencing | Puromycin | 3 |